Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice

With the widespread vaccinations against coronavirus disease 2019 (COVID-19), we are witnessing gradually waning neutralizing antibodies and increasing cases of breakthrough infections, necessitating the development of drugs aside from vaccines, particularly ones that can be administered outside of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Honghui, Wu, Lili, Liu, Bo, Xu, Ke, Lei, Wenwen, Deng, Jianguo, Rong, Xiaoyu, Du, Pei, Wang, Lebing, Wang, Dongbin, Zhang, Xiaolong, Su, Chao, Bi, Yuhai, Chen, Hua, Liu, William J., Qi, Jianxun, Cui, Qingwei, Qi, Shuhui, Fan, Ruiwen, Jiang, Jingkun, Wu, Guizhen, Gao, George F., Wang, Qihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834170/
https://www.ncbi.nlm.nih.gov/pubmed/36702124
http://dx.doi.org/10.1016/j.xcrm.2023.100918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834170/
https://www.ncbi.nlm.nih.gov/pubmed/36702124
http://dx.doi.org/10.1016/j.xcrm.2023.100918

Ejemplares similares